ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.3750
-0.0170 (-4.34%)
Mar 31, 2025, 3:47 PM EDT - Market open

ImmunoPrecise Antibodies Income Statement

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2019 - 2015
Revenue
2424.5220.6719.3617.9114.06
Upgrade
Revenue Growth (YoY)
1.35%18.64%6.72%8.11%27.41%28.66%
Upgrade
Cost of Revenue
11.812.479.18.386.516.1
Upgrade
Gross Profit
12.212.0511.5610.9811.47.95
Upgrade
Selling, General & Admin
19.3219.1418.1918.0610.598.24
Upgrade
Research & Development
5.114.0414.17.661.970.45
Upgrade
Operating Expenses
26.9826.1536.7127.7318.0612.05
Upgrade
Operating Income
-14.78-14.09-25.14-16.75-6.65-4.09
Upgrade
Interest Expense
-0.33-0.02-0-0.09-0.64-0.7
Upgrade
Interest & Investment Income
0.020.020.120.280.280.05
Upgrade
Currency Exchange Gain (Loss)
-0.090.090.230.63-1.230.08
Upgrade
Other Non Operating Income (Expenses)
0.20.330.310.08-0.22-0.73
Upgrade
EBT Excluding Unusual Items
-14.98-13.67-24.49-15.85-8.47-5.4
Upgrade
Merger & Restructuring Charges
---0.8---
Upgrade
Impairment of Goodwill
-11.16-11.16-2.46---
Upgrade
Asset Writedown
-25.05-3.87----
Upgrade
Other Unusual Items
----2.470.11
Upgrade
Pretax Income
-51.19-28.7-27.75-15.85-6-5.29
Upgrade
Income Tax Expense
-4.45-1.53-1.190.861.35-0.35
Upgrade
Net Income
-46.75-27.18-26.56-16.71-7.34-4.95
Upgrade
Net Income to Common
-46.75-27.18-26.56-16.71-7.34-4.95
Upgrade
Shares Outstanding (Basic)
292625201614
Upgrade
Shares Outstanding (Diluted)
292625201614
Upgrade
Shares Change (YoY)
13.69%2.97%26.46%19.51%20.88%8.67%
Upgrade
EPS (Basic)
-1.63-1.06-1.07-0.85-0.45-0.36
Upgrade
EPS (Diluted)
-1.63-1.06-1.07-0.85-0.45-0.36
Upgrade
Free Cash Flow
-9.48-5.64-21.33-10.99-2.03-1.85
Upgrade
Free Cash Flow Per Share
-0.33-0.22-0.86-0.56-0.12-0.14
Upgrade
Gross Margin
50.82%49.16%55.95%56.72%63.67%56.58%
Upgrade
Operating Margin
-61.60%-57.48%-121.67%-86.49%-37.14%-29.12%
Upgrade
Profit Margin
-194.79%-110.84%-128.53%-86.29%-40.98%-35.19%
Upgrade
Free Cash Flow Margin
-39.50%-23.02%-103.21%-56.74%-11.32%-13.18%
Upgrade
EBITDA
-11.01-10.37-21.31-12.98-4.6-2.39
Upgrade
EBITDA Margin
-45.89%-42.30%-103.11%-67.03%-25.66%-16.99%
Upgrade
D&A For EBITDA
3.773.723.843.772.061.71
Upgrade
EBIT
-14.78-14.09-25.14-16.75-6.65-4.09
Upgrade
EBIT Margin
-61.60%-57.48%-121.67%-86.49%-37.14%-29.12%
Upgrade
Advertising Expenses
----0.690.38
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q